We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14
Avg Time Held Equity + Options
1.3 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.2 years

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV icon
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT icon
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT icon
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GOSS icon
51
Gossamer Bio
GOSS
$53.3M
$3.69M 0.31%
55,348
+45,977
+491% +$4.24M
2021 Q3
8 quarters
RVTY icon
52
Revvity
RVTY
$17B
$3.62M 0.31%
32,698
+11,384
+53% +$1.34M
2021 Q3
8 quarters
CVAC icon
53
DELISTED
CureVac
CVAC
$3.53M 0.3%
516,794
+159,452
+45% +$1.41M
2023 Q2
1 quarter
BHVN icon
54
Biohaven
BHVN
$1.64B
$3.41M 0.29%
131,103
– –
2022 Q4
3 quarters
PODD icon
55
Insulet
PODD
$9.81B
$3.4M 0.29%
+21,299
New +$4.77M
2023 Q3
0 quarters
MRUS icon
56
DELISTED
Merus
MRUS
$3.16M 0.27%
134,010
+2,784
+2% +$67.5K
2021 Q4
7 quarters
STRO icon
57
Sutro Biopharma
STRO
$183M
$2.67M 0.23%
76,964
+2,173
+3% +$94.7K
2023 Q2
1 quarter
RGEN icon
58
Repligen
RGEN
$11.1B
$2.57M 0.22%
16,153
-49,914
-76% -$8.16M
2021 Q1
10 quarters
ARGX icon
59
argenx
ARGX
$51.6B
$2.24M 0.19%
4,565
+411
+10% +$201K
2021 Q3
8 quarters
MEDP icon
60
Medpace
MEDP
$17.2B
$2.14M 0.18%
8,823
-6,741
-43% -$1.72M
2023 Q1
2 quarters
AVTR icon
61
Avantor
AVTR
$10.9B
$1.78M 0.15%
+84,495
New +$1.8M
2023 Q3
0 quarters
BBIO icon
62
PUT
BridgeBio Pharma
BBIO
$13B
$1.47M 0.12%
+55,800
New +$1.58M
2023 Q3
0 quarters
XBI icon
63
State Street SPDR S&P Biotech ETF
XBI
$9.52B
$1.46M 0.12%
+20,000
New +$1.6M
2023 Q3
0 quarters
XOMA icon
64
DELISTED
Xoma
XOMA
$1.27M 0.11%
89,950
– –
2022 Q3
4 quarters
BDTX icon
65
Black Diamond Therapeutics
BDTX
$98.2M
$968K 0.08%
337,131
-90,186
-21% -$332K
2023 Q2
1 quarter
AFMD icon
66
DELISTED
Affimed
AFMD
$801K 0.07%
167,668
– –
2022 Q2
5 quarters
JBIO icon
67
Jade Biosciences
JBIO
$856M
$682K 0.06%
1,435
– –
2022 Q4
3 quarters
WHWK icon
68
Whitehawk Therapeutics
WHWK
$165M
$493K 0.04%
101,918
– –
2022 Q1
6 quarters
ACIU icon
69
AC Immune
ACIU
$239M
$355K 0.03%
124,589
– –
2021 Q3
8 quarters
EHTH icon
70
eHealth
EHTH
$18.4M
– –
-503,079
Closed -$4.04M –
EOLS icon
71
Evolus
EOLS
$468M
– –
-228,679
Closed -$1.66M –
KYNB icon
72
Kyntra Bio
KYNB
$20M
– –
-224
Closed -$15.1K –
KYNB icon
73
PUT
Kyntra Bio
KYNB
$20M
– –
-1,552
Closed -$105K –
GOCO icon
74
DELISTED
GoHealth
GOCO
– –
-104,820
Closed -$2.07M –
KURA icon
75
Kura Oncology
KURA
$807M
– –
-450,622
Closed -$4.77M –
1 2
3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.